Moderate/high expression of INF2 associated with significantly impaired prognosis. »
07/29/20

No significant difference in either PFS or OSobserved with addition of PCV. »
07/25/20

Immunotherapy-associated toxicity minimal. »
05/23/20

Postoperative complications ypN, tumor differentiation, and LVI as independent variables for RFS. »
05/09/20

Overexpression of HLCS reduced survival time of patients with breast cancer. »
06/08/20

Neoadjuvant immunotherapy effective and safe. »
04/20/20

Significant changes observed in women with early stage and metastatic cancer. »
05/28/20

Only PIRADS category of 5 and PSAD found to be associated with progression on AS. »
07/28/20

Survival from stage I cervical cancer in young women in England excellent. »
06/10/20

EMDA-MMC BCG represents viable option in patients with BCG unresponsive NMIBC. »
02/06/20